Home Cart Sign in  
Chemical Structure| 1606974-33-7 Chemical Structure| 1606974-33-7

Structure of Zatolmilast
CAS No.: 1606974-33-7

Chemical Structure| 1606974-33-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Zatolmilast is a selective PDE4D allosteric inhibitor suitable for research in neurological diseases.

Synonyms: BPN14770

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Zatolmilast

CAS No. :1606974-33-7
Formula : C21H15ClF3NO2
M.W : 405.80
SMILES Code : ClC1=CC=CC(C2=CC(CC3=CC=C(CC(O)=O)C=C3)=CC(C(F)(F)F)=N2)=C1
Synonyms :
BPN14770
MDL No. :MFCD32067916

Safety of Zatolmilast

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319
Precautionary Statements:P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
BV-2 cells ≤10 µM 24 h Evaluate the effect of Zatolmilast on LPS-induced NO and TNF-α production, results showed Zatolmilast had no anti-neuroinflammatory effects. PMC10391911

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
C57BL/6J mice LPS-induced neuroinflammation model Oral 10 mg/kg Once daily for 4 consecutive days Evaluate the anti-neuroinflammatory effects of Zatolmilast in vivo, results showed Zatolmilast had no anti-neuroinflammatory effects. PMC10391911

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.46mL

0.49mL

0.25mL

12.32mL

2.46mL

1.23mL

24.64mL

4.93mL

2.46mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories